HOME | CONTACT US | LOGIN | REGISTER
 
TECHNOLOGY
RapidMist™
  Formulation
Device
Buccal Delivery
Large Molecule Drugs Challenge
Immunomedicines
  li Suppression
li-Key Hybrid
 
Generex Technology
 
Generex have many platform technologies in the area of drug delivery and immunomedicines.
 
 Inhaler

RapidMist ™, Generex’s advanced buccal drug delivery technology, is comprised of a proprietary formulation and a proprietary device design that is able to deliver drugs through the buccal mucosa safely, thereby eliminating the pain from and need for multiple injections.  RapidMist™ has been shown to have a rapid onset of action with no lung deposition, precise dosage control, easy use and handling, and improved patient compliance.

   
 

Antigen Express technology focuses on modulating immune responses mediated by T helper (Th) cells, a class of lymphocytes that plays a multifaceted role in the immune system, both enhancing and suppressing immune responses. The cells are essential both for obtaining a robust and long lasting response against infectious agents or cancer cells and for down regulating immune responses when the immune system becomes inappropriately stimulated, e.g. in autoimmune disease and allergy.

   
Product Pipeline
Generex Products Pipeline